INDUCTION OF LEUKEMIA INHIBITORY FACTOR IN HUMAN SYNOVIAL FIBROBLASTS BY IL-1 AND TUMOR-NECROSIS-FACTOR-ALPHA
- Author(s)
- Hamilton, JA; Waring, PM; Filonzi, EL;
- Details
- Publication Year 1993-02-15,Volume 150,Issue #4,Page 1496-1502
- Journal Title
- JOURNAL OF IMMUNOLOGY
- Publication Type
- Journal Article
- Abstract
- The cytokines, IL-1alpha and TNF-alpha, induced a dose-dependent production of leukemia inhibitory factor (LIF) in cultured human synovial fibroblast-like cells, as measured by a radioreceptor competition assay. Significant levels of LIF were first detected in cell supernatants between 2 and 4 h after cytokine addition. Increases were also observed in LIF mRNA steady-state expression. Evidence is presented for down-regulation of the IL-1-induced LIF activity by an endogenous cyclo-oxygenase product(s); the glucocorticoid, dexamethasone, lowered the IL-1-induced LIF activity and mRNA expression. A synergistic effect was noted between the actions of IL-1alpha and TNF-alpha, and between IL-1 and transforming growth factor-beta. IFN-gamma could not induce LIF formation in the synovial cells but inhibited the stimulatory effect of IL-1. These results suggest that cytokine-stimulated synovial fibroblasts may be a major source of intraarticular LIF production in the joints of patients with inflammatory arthritis. Synoviocyte-derived LIF may activate monocyte/macrophages in the lesions and may contribute to the bone changes and certain systemic manifestations in patients with inflammatory joint disease.
- Publisher
- AMER ASSOC IMMUNOLOGISTS
- Keywords
- PLASMINOGEN-ACTIVATOR; RHEUMATOID-ARTHRITIS; DNA-SYNTHESIS; GROWTH-FACTOR; CELLS; STIMULATION; INTERLEUKIN-1; CYTOKINES; ACID; BETA
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 1993-02-15 12:00:00